Advertisement
Research Article Free access | 10.1172/JCI1582
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Lerman, B. in: JCI | PubMed | Google Scholar
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Dong, B. in: JCI | PubMed | Google Scholar
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Stein, K. in: JCI | PubMed | Google Scholar
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Markowitz, S. in: JCI | PubMed | Google Scholar
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Linden, J. in: JCI | PubMed | Google Scholar
Department of Medicine, Division of Cardiology, The New York Hospital-Cornell Medical Center, New York, 10021, USA. blerman@mail.med.cornell.edu
Find articles by Catanzaro, D. in: JCI | PubMed | Google Scholar
Published June 15, 1998 - More info
Idiopathic ventricular tachycardia is a generic term that describes the various forms of ventricular arrhythmias that occur in patients without structural heart disease and in the absence of the long QT syndrome. Many of these tachycardias are focal in origin, localize to the right ventricular outflow tract (RVOT), terminate in response to beta blockers, verapamil, vagal maneuvers, and adenosine, and are thought to result from cAMP-mediated triggered activity. DNA was prepared from biopsy samples obtained from myocardial tissue from a patient with adenosine-insensitive idiopathic ventricular tachycardia arising from the RVOT. Genomic sequences of the inhibitory G protein Galphai2 were determined after amplification by PCR and subcloning. A point mutation (F200L) in the GTP binding domain of the inhibitory G protein Galphai2 was identified in a biopsy sample from the arrhythmogenic focus. This mutation was shown to increase intracellular cAMP concentration and inhibit suppression of cAMP by adenosine. No mutations were detected in Galphai2 sequences from myocardial tissue sampled from regions remote from the origin of tachycardia, or from peripheral lymphocytes. These findings suggest that somatic cell mutations in the cAMP-dependent signal transduction pathway occurring during myocardial development may be responsible for some forms of idiopathic ventricular tachycardia.